0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Long-acting Glucocorticoid Injection Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-32Z17035
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Long acting Glucocorticoid Injection Market Research Report 2024
BUY CHAPTERS

Global Long-acting Glucocorticoid Injection Market Research Report 2024

Code: QYRE-Auto-32Z17035
Report
May 2024
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Long-acting Glucocorticoid Injection Market

Long-acting glucocorticoid injection is a drug with anti-inflammatory, anti-rheumatic and immunosuppressive effects, and is often used to treat allergic and autoimmune inflammatory diseases.
The global Long-acting Glucocorticoid Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Long-acting Glucocorticoid Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Long-acting Glucocorticoid Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Long-acting Glucocorticoid Injection include Eurocrit Labs, Pyxus Pharmaceutical, SiNi Pharma, Zydus Cadila, Weefsel Pharma, Taj Pharmaceuticals Limited, Wellona Pharma, Caspian Tamin Pharmaceutical Company, AdvaCare Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Long-acting Glucocorticoid Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting Glucocorticoid Injection.
The Long-acting Glucocorticoid Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Long-acting Glucocorticoid Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-acting Glucocorticoid Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Long-acting Glucocorticoid Injection Market Report

Report Metric Details
Report Name Long-acting Glucocorticoid Injection Market
Segment by Type
  • Dexamethasone Hormone Injection
  • Betamethasone Hormone Injection
Segment by Application
  • Rheumatoid Arthritis
  • Allergic Diseases
  • Bronchial Asthma
  • Autoimmune Disease
  • Skin Diseases
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eurocrit Labs, Pyxus Pharmaceutical, SiNi Pharma, Zydus Cadila, Weefsel Pharma, Taj Pharmaceuticals Limited, Wellona Pharma, Caspian Tamin Pharmaceutical Company, AdvaCare Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Long-acting Glucocorticoid Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Long-acting Glucocorticoid Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Long-acting Glucocorticoid Injection Market report?

Ans: The main players in the Long-acting Glucocorticoid Injection Market are Eurocrit Labs, Pyxus Pharmaceutical, SiNi Pharma, Zydus Cadila, Weefsel Pharma, Taj Pharmaceuticals Limited, Wellona Pharma, Caspian Tamin Pharmaceutical Company, AdvaCare Pharma

What are the Application segmentation covered in the Long-acting Glucocorticoid Injection Market report?

Ans: The Applications covered in the Long-acting Glucocorticoid Injection Market report are Rheumatoid Arthritis, Allergic Diseases, Bronchial Asthma, Autoimmune Disease, Skin Diseases, Others

What are the Type segmentation covered in the Long-acting Glucocorticoid Injection Market report?

Ans: The Types covered in the Long-acting Glucocorticoid Injection Market report are Dexamethasone Hormone Injection, Betamethasone Hormone Injection

1 Long-acting Glucocorticoid Injection Market Overview
1.1 Product Definition
1.2 Long-acting Glucocorticoid Injection by Type
1.2.1 Global Long-acting Glucocorticoid Injection Market Value Comparison by Type (2024-2030)
1.2.2 Dexamethasone Hormone Injection
1.2.3 Betamethasone Hormone Injection
1.3 Long-acting Glucocorticoid Injection by Application
1.3.1 Global Long-acting Glucocorticoid Injection Market Value by Application (2024-2030)
1.3.2 Rheumatoid Arthritis
1.3.3 Allergic Diseases
1.3.4 Bronchial Asthma
1.3.5 Autoimmune Disease
1.3.6 Skin Diseases
1.3.7 Others
1.4 Global Long-acting Glucocorticoid Injection Market Size Estimates and Forecasts
1.4.1 Global Long-acting Glucocorticoid Injection Revenue 2019-2030
1.4.2 Global Long-acting Glucocorticoid Injection Sales 2019-2030
1.4.3 Global Long-acting Glucocorticoid Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Long-acting Glucocorticoid Injection Market Competition by Manufacturers
2.1 Global Long-acting Glucocorticoid Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Long-acting Glucocorticoid Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Long-acting Glucocorticoid Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Long-acting Glucocorticoid Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Long-acting Glucocorticoid Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Long-acting Glucocorticoid Injection, Product Type & Application
2.7 Global Key Manufacturers of Long-acting Glucocorticoid Injection, Date of Enter into This Industry
2.8 Global Long-acting Glucocorticoid Injection Market Competitive Situation and Trends
2.8.1 Global Long-acting Glucocorticoid Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Long-acting Glucocorticoid Injection Players Market Share by Revenue
2.8.3 Global Long-acting Glucocorticoid Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-acting Glucocorticoid Injection Market Scenario by Region
3.1 Global Long-acting Glucocorticoid Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Long-acting Glucocorticoid Injection Sales by Region: 2019-2030
3.2.1 Global Long-acting Glucocorticoid Injection Sales by Region: 2019-2024
3.2.2 Global Long-acting Glucocorticoid Injection Sales by Region: 2025-2030
3.3 Global Long-acting Glucocorticoid Injection Revenue by Region: 2019-2030
3.3.1 Global Long-acting Glucocorticoid Injection Revenue by Region: 2019-2024
3.3.2 Global Long-acting Glucocorticoid Injection Revenue by Region: 2025-2030
3.4 North America Long-acting Glucocorticoid Injection Market Facts & Figures by Country
3.4.1 North America Long-acting Glucocorticoid Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Long-acting Glucocorticoid Injection Sales by Country (2019-2030)
3.4.3 North America Long-acting Glucocorticoid Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-acting Glucocorticoid Injection Market Facts & Figures by Country
3.5.1 Europe Long-acting Glucocorticoid Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Long-acting Glucocorticoid Injection Sales by Country (2019-2030)
3.5.3 Europe Long-acting Glucocorticoid Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-acting Glucocorticoid Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Long-acting Glucocorticoid Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Long-acting Glucocorticoid Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Long-acting Glucocorticoid Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-acting Glucocorticoid Injection Market Facts & Figures by Country
3.7.1 Latin America Long-acting Glucocorticoid Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Long-acting Glucocorticoid Injection Sales by Country (2019-2030)
3.7.3 Latin America Long-acting Glucocorticoid Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Long-acting Glucocorticoid Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-acting Glucocorticoid Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Long-acting Glucocorticoid Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Long-acting Glucocorticoid Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-acting Glucocorticoid Injection Sales by Type (2019-2030)
4.1.1 Global Long-acting Glucocorticoid Injection Sales by Type (2019-2024)
4.1.2 Global Long-acting Glucocorticoid Injection Sales by Type (2025-2030)
4.1.3 Global Long-acting Glucocorticoid Injection Sales Market Share by Type (2019-2030)
4.2 Global Long-acting Glucocorticoid Injection Revenue by Type (2019-2030)
4.2.1 Global Long-acting Glucocorticoid Injection Revenue by Type (2019-2024)
4.2.2 Global Long-acting Glucocorticoid Injection Revenue by Type (2025-2030)
4.2.3 Global Long-acting Glucocorticoid Injection Revenue Market Share by Type (2019-2030)
4.3 Global Long-acting Glucocorticoid Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Long-acting Glucocorticoid Injection Sales by Application (2019-2030)
5.1.1 Global Long-acting Glucocorticoid Injection Sales by Application (2019-2024)
5.1.2 Global Long-acting Glucocorticoid Injection Sales by Application (2025-2030)
5.1.3 Global Long-acting Glucocorticoid Injection Sales Market Share by Application (2019-2030)
5.2 Global Long-acting Glucocorticoid Injection Revenue by Application (2019-2030)
5.2.1 Global Long-acting Glucocorticoid Injection Revenue by Application (2019-2024)
5.2.2 Global Long-acting Glucocorticoid Injection Revenue by Application (2025-2030)
5.2.3 Global Long-acting Glucocorticoid Injection Revenue Market Share by Application (2019-2030)
5.3 Global Long-acting Glucocorticoid Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eurocrit Labs
6.1.1 Eurocrit Labs Company Information
6.1.2 Eurocrit Labs Description and Business Overview
6.1.3 Eurocrit Labs Long-acting Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eurocrit Labs Long-acting Glucocorticoid Injection Product Portfolio
6.1.5 Eurocrit Labs Recent Developments/Updates
6.2 Pyxus Pharmaceutical
6.2.1 Pyxus Pharmaceutical Company Information
6.2.2 Pyxus Pharmaceutical Description and Business Overview
6.2.3 Pyxus Pharmaceutical Long-acting Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pyxus Pharmaceutical Long-acting Glucocorticoid Injection Product Portfolio
6.2.5 Pyxus Pharmaceutical Recent Developments/Updates
6.3 SiNi Pharma
6.3.1 SiNi Pharma Company Information
6.3.2 SiNi Pharma Description and Business Overview
6.3.3 SiNi Pharma Long-acting Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SiNi Pharma Long-acting Glucocorticoid Injection Product Portfolio
6.3.5 SiNi Pharma Recent Developments/Updates
6.4 Zydus Cadila
6.4.1 Zydus Cadila Company Information
6.4.2 Zydus Cadila Description and Business Overview
6.4.3 Zydus Cadila Long-acting Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zydus Cadila Long-acting Glucocorticoid Injection Product Portfolio
6.4.5 Zydus Cadila Recent Developments/Updates
6.5 Weefsel Pharma
6.5.1 Weefsel Pharma Company Information
6.5.2 Weefsel Pharma Description and Business Overview
6.5.3 Weefsel Pharma Long-acting Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Weefsel Pharma Long-acting Glucocorticoid Injection Product Portfolio
6.5.5 Weefsel Pharma Recent Developments/Updates
6.6 Taj Pharmaceuticals Limited
6.6.1 Taj Pharmaceuticals Limited Company Information
6.6.2 Taj Pharmaceuticals Limited Description and Business Overview
6.6.3 Taj Pharmaceuticals Limited Long-acting Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Taj Pharmaceuticals Limited Long-acting Glucocorticoid Injection Product Portfolio
6.6.5 Taj Pharmaceuticals Limited Recent Developments/Updates
6.7 Wellona Pharma
6.7.1 Wellona Pharma Company Information
6.7.2 Wellona Pharma Description and Business Overview
6.7.3 Wellona Pharma Long-acting Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Wellona Pharma Long-acting Glucocorticoid Injection Product Portfolio
6.7.5 Wellona Pharma Recent Developments/Updates
6.8 Caspian Tamin Pharmaceutical Company
6.8.1 Caspian Tamin Pharmaceutical Company Company Information
6.8.2 Caspian Tamin Pharmaceutical Company Description and Business Overview
6.8.3 Caspian Tamin Pharmaceutical Company Long-acting Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Caspian Tamin Pharmaceutical Company Long-acting Glucocorticoid Injection Product Portfolio
6.8.5 Caspian Tamin Pharmaceutical Company Recent Developments/Updates
6.9 AdvaCare Pharma
6.9.1 AdvaCare Pharma Company Information
6.9.2 AdvaCare Pharma Description and Business Overview
6.9.3 AdvaCare Pharma Long-acting Glucocorticoid Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AdvaCare Pharma Long-acting Glucocorticoid Injection Product Portfolio
6.9.5 AdvaCare Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-acting Glucocorticoid Injection Industry Chain Analysis
7.2 Long-acting Glucocorticoid Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-acting Glucocorticoid Injection Production Mode & Process
7.4 Long-acting Glucocorticoid Injection Sales and Marketing
7.4.1 Long-acting Glucocorticoid Injection Sales Channels
7.4.2 Long-acting Glucocorticoid Injection Distributors
7.5 Long-acting Glucocorticoid Injection Customers
8 Long-acting Glucocorticoid Injection Market Dynamics
8.1 Long-acting Glucocorticoid Injection Industry Trends
8.2 Long-acting Glucocorticoid Injection Market Drivers
8.3 Long-acting Glucocorticoid Injection Market Challenges
8.4 Long-acting Glucocorticoid Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Long-acting Glucocorticoid Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Long-acting Glucocorticoid Injection Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Long-acting Glucocorticoid Injection Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Long-acting Glucocorticoid Injection Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Long-acting Glucocorticoid Injection Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Long-acting Glucocorticoid Injection Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Long-acting Glucocorticoid Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Long-acting Glucocorticoid Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Long-acting Glucocorticoid Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Long-acting Glucocorticoid Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Long-acting Glucocorticoid Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Long-acting Glucocorticoid Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Glucocorticoid Injection as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Long-acting Glucocorticoid Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Long-acting Glucocorticoid Injection Sales by Region (2019-2024) & (K Units)
 Table 18. Global Long-acting Glucocorticoid Injection Sales Market Share by Region (2019-2024)
 Table 19. Global Long-acting Glucocorticoid Injection Sales by Region (2025-2030) & (K Units)
 Table 20. Global Long-acting Glucocorticoid Injection Sales Market Share by Region (2025-2030)
 Table 21. Global Long-acting Glucocorticoid Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Long-acting Glucocorticoid Injection Revenue Market Share by Region (2019-2024)
 Table 23. Global Long-acting Glucocorticoid Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Long-acting Glucocorticoid Injection Revenue Market Share by Region (2025-2030)
 Table 25. North America Long-acting Glucocorticoid Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Long-acting Glucocorticoid Injection Sales by Country (2019-2024) & (K Units)
 Table 27. North America Long-acting Glucocorticoid Injection Sales by Country (2025-2030) & (K Units)
 Table 28. North America Long-acting Glucocorticoid Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Long-acting Glucocorticoid Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Long-acting Glucocorticoid Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Long-acting Glucocorticoid Injection Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Long-acting Glucocorticoid Injection Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Long-acting Glucocorticoid Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Long-acting Glucocorticoid Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Long-acting Glucocorticoid Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Long-acting Glucocorticoid Injection Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Long-acting Glucocorticoid Injection Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Long-acting Glucocorticoid Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Long-acting Glucocorticoid Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Long-acting Glucocorticoid Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Long-acting Glucocorticoid Injection Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Long-acting Glucocorticoid Injection Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Long-acting Glucocorticoid Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Long-acting Glucocorticoid Injection Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Long-acting Glucocorticoid Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Long-acting Glucocorticoid Injection Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Long-acting Glucocorticoid Injection Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Long-acting Glucocorticoid Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Long-acting Glucocorticoid Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Long-acting Glucocorticoid Injection Sales (K Units) by Type (2019-2024)
 Table 51. Global Long-acting Glucocorticoid Injection Sales (K Units) by Type (2025-2030)
 Table 52. Global Long-acting Glucocorticoid Injection Sales Market Share by Type (2019-2024)
 Table 53. Global Long-acting Glucocorticoid Injection Sales Market Share by Type (2025-2030)
 Table 54. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Long-acting Glucocorticoid Injection Revenue Market Share by Type (2019-2024)
 Table 57. Global Long-acting Glucocorticoid Injection Revenue Market Share by Type (2025-2030)
 Table 58. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Long-acting Glucocorticoid Injection Sales (K Units) by Application (2019-2024)
 Table 61. Global Long-acting Glucocorticoid Injection Sales (K Units) by Application (2025-2030)
 Table 62. Global Long-acting Glucocorticoid Injection Sales Market Share by Application (2019-2024)
 Table 63. Global Long-acting Glucocorticoid Injection Sales Market Share by Application (2025-2030)
 Table 64. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Long-acting Glucocorticoid Injection Revenue Market Share by Application (2019-2024)
 Table 67. Global Long-acting Glucocorticoid Injection Revenue Market Share by Application (2025-2030)
 Table 68. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Application (2025-2030)
 Table 70. Eurocrit Labs Company Information
 Table 71. Eurocrit Labs Description and Business Overview
 Table 72. Eurocrit Labs Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Eurocrit Labs Long-acting Glucocorticoid Injection Product
 Table 74. Eurocrit Labs Recent Developments/Updates
 Table 75. Pyxus Pharmaceutical Company Information
 Table 76. Pyxus Pharmaceutical Description and Business Overview
 Table 77. Pyxus Pharmaceutical Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Pyxus Pharmaceutical Long-acting Glucocorticoid Injection Product
 Table 79. Pyxus Pharmaceutical Recent Developments/Updates
 Table 80. SiNi Pharma Company Information
 Table 81. SiNi Pharma Description and Business Overview
 Table 82. SiNi Pharma Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. SiNi Pharma Long-acting Glucocorticoid Injection Product
 Table 84. SiNi Pharma Recent Developments/Updates
 Table 85. Zydus Cadila Company Information
 Table 86. Zydus Cadila Description and Business Overview
 Table 87. Zydus Cadila Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Zydus Cadila Long-acting Glucocorticoid Injection Product
 Table 89. Zydus Cadila Recent Developments/Updates
 Table 90. Weefsel Pharma Company Information
 Table 91. Weefsel Pharma Description and Business Overview
 Table 92. Weefsel Pharma Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Weefsel Pharma Long-acting Glucocorticoid Injection Product
 Table 94. Weefsel Pharma Recent Developments/Updates
 Table 95. Taj Pharmaceuticals Limited Company Information
 Table 96. Taj Pharmaceuticals Limited Description and Business Overview
 Table 97. Taj Pharmaceuticals Limited Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Taj Pharmaceuticals Limited Long-acting Glucocorticoid Injection Product
 Table 99. Taj Pharmaceuticals Limited Recent Developments/Updates
 Table 100. Wellona Pharma Company Information
 Table 101. Wellona Pharma Description and Business Overview
 Table 102. Wellona Pharma Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Wellona Pharma Long-acting Glucocorticoid Injection Product
 Table 104. Wellona Pharma Recent Developments/Updates
 Table 105. Caspian Tamin Pharmaceutical Company Company Information
 Table 106. Caspian Tamin Pharmaceutical Company Description and Business Overview
 Table 107. Caspian Tamin Pharmaceutical Company Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Caspian Tamin Pharmaceutical Company Long-acting Glucocorticoid Injection Product
 Table 109. Caspian Tamin Pharmaceutical Company Recent Developments/Updates
 Table 110. AdvaCare Pharma Company Information
 Table 111. AdvaCare Pharma Description and Business Overview
 Table 112. AdvaCare Pharma Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. AdvaCare Pharma Long-acting Glucocorticoid Injection Product
 Table 114. AdvaCare Pharma Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Long-acting Glucocorticoid Injection Distributors List
 Table 118. Long-acting Glucocorticoid Injection Customers List
 Table 119. Long-acting Glucocorticoid Injection Market Trends
 Table 120. Long-acting Glucocorticoid Injection Market Drivers
 Table 121. Long-acting Glucocorticoid Injection Market Challenges
 Table 122. Long-acting Glucocorticoid Injection Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Long-acting Glucocorticoid Injection
 Figure 2. Global Long-acting Glucocorticoid Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Long-acting Glucocorticoid Injection Market Share by Type: 2023 & 2030
 Figure 4. Dexamethasone Hormone Injection Product Picture
 Figure 5. Betamethasone Hormone Injection Product Picture
 Figure 6. Global Long-acting Glucocorticoid Injection Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Long-acting Glucocorticoid Injection Market Share by Application: 2023 & 2030
 Figure 8. Rheumatoid Arthritis
 Figure 9. Allergic Diseases
 Figure 10. Bronchial Asthma
 Figure 11. Autoimmune Disease
 Figure 12. Skin Diseases
 Figure 13. Others
 Figure 14. Global Long-acting Glucocorticoid Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Long-acting Glucocorticoid Injection Market Size (2019-2030) & (US$ Million)
 Figure 16. Global Long-acting Glucocorticoid Injection Sales (2019-2030) & (K Units)
 Figure 17. Global Long-acting Glucocorticoid Injection Average Price (US$/Unit) & (2019-2030)
 Figure 18. Long-acting Glucocorticoid Injection Report Years Considered
 Figure 19. Long-acting Glucocorticoid Injection Sales Share by Manufacturers in 2023
 Figure 20. Global Long-acting Glucocorticoid Injection Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest Long-acting Glucocorticoid Injection Players: Market Share by Revenue in Long-acting Glucocorticoid Injection in 2023
 Figure 22. Long-acting Glucocorticoid Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global Long-acting Glucocorticoid Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America Long-acting Glucocorticoid Injection Sales Market Share by Country (2019-2030)
 Figure 25. North America Long-acting Glucocorticoid Injection Revenue Market Share by Country (2019-2030)
 Figure 26. United States Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe Long-acting Glucocorticoid Injection Sales Market Share by Country (2019-2030)
 Figure 29. Europe Long-acting Glucocorticoid Injection Revenue Market Share by Country (2019-2030)
 Figure 30. Germany Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific Long-acting Glucocorticoid Injection Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific Long-acting Glucocorticoid Injection Revenue Market Share by Region (2019-2030)
 Figure 37. China Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Latin America Long-acting Glucocorticoid Injection Sales Market Share by Country (2019-2030)
 Figure 45. Mexico Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Brazil Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Argentina Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Colombia Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Middle East and Africa Long-acting Glucocorticoid Injection Sales Market Share by Country (2019-2030)
 Figure 50. Middle East and Africa Long-acting Glucocorticoid Injection Revenue Market Share by Country (2019-2030)
 Figure 51. Turkey Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. UAE Long-acting Glucocorticoid Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Global Sales Market Share of Long-acting Glucocorticoid Injection by Type (2019-2030)
 Figure 55. Global Revenue Market Share of Long-acting Glucocorticoid Injection by Type (2019-2030)
 Figure 56. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Type (2019-2030)
 Figure 57. Global Sales Market Share of Long-acting Glucocorticoid Injection by Application (2019-2030)
 Figure 58. Global Revenue Market Share of Long-acting Glucocorticoid Injection by Application (2019-2030)
 Figure 59. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Application (2019-2030)
 Figure 60. Long-acting Glucocorticoid Injection Value Chain
 Figure 61. Long-acting Glucocorticoid Injection Production Process
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String
OSZAR »